The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to issue a sole-source fixed-price purchase order to Sebia Inc. for the procurement of proprietary Hydrasys 2 reagent kits and associated quality control materials necessary for electrophoresis testing within the Department of Laboratory Medicine. This acquisition aims to support patient care by providing essential tools for the separation and quantification of proteins in human serum and urine, as well as for the detection of monoclonal proteins, which are critical for monitoring patients with B-cell malignancies and central nervous system diseases. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by April 3, 2025, as this is not a request for quotations and the procurement is being conducted under special sole-source acquisition regulations.